Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Analysts

Stevanato Group S.p.A. (NYSE:STVN) has received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.

STVN has been the topic of a number of recent research reports. Morgan Stanley reaffirmed an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America lifted their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Finally, Wolfe Research initiated coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company.

Stevanato Group Stock Up 1.7 %

Shares of STVN opened at €22.31 ($23.24) on Friday. The firm has a market cap of $6.76 billion, a PE ratio of 47.47, a price-to-earnings-growth ratio of 7.42 and a beta of 0.56. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The company’s fifty day moving average is €21.73 and its two-hundred day moving average is €20.52. Stevanato Group has a fifty-two week low of €16.56 ($17.25) and a fifty-two week high of €34.73 ($36.18).

Stevanato Group (NYSE:STVN) last issued its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Stevanato Group’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.16 EPS. Analysts forecast that Stevanato Group will post 0.5 earnings per share for the current year.

Institutional Investors Weigh In On Stevanato Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Squarepoint Ops LLC increased its holdings in Stevanato Group by 65.6% during the 2nd quarter. Squarepoint Ops LLC now owns 17,302 shares of the company’s stock worth $317,000 after purchasing an additional 6,853 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Stevanato Group by 222.3% during the second quarter. The Manufacturers Life Insurance Company now owns 251,606 shares of the company’s stock worth $4,614,000 after buying an additional 173,546 shares in the last quarter. Truist Financial Corp increased its stake in shares of Stevanato Group by 47.0% in the second quarter. Truist Financial Corp now owns 26,034 shares of the company’s stock worth $477,000 after buying an additional 8,321 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Stevanato Group in the third quarter valued at $263,000. Finally, nVerses Capital LLC bought a new position in Stevanato Group during the 3rd quarter valued at $84,000.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.